Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2024 financial results on Wednesday, May 1, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world ? from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.
Fifty-eight percent of bankers would take action to reduce costs or increase revenue elsewhere even if exempt under a new regulatory proposal to restrict overdraft fees, according to a survey of nearly 500 financial executives released today.
In a...
Smallstep Labs, a pioneer in streamlining secure device identity and champion of the Zero Trust approach to security, unveiled market data that shows an impressive 78% of the Fortune 100 companies actively engage with Smallstep's open source...
Aubex Therapeutics Inc., a pioneering biotechnology firm, announced its official launch, heralding a new era in the battle against cancer. Under the guidance of Board Member and Interim CEO, Jeffrey Glazer, Aubex's initial program is focused on novel...
AdGPT, the world's first fully automated ad creative tool for SMBs, today announced its launch out of stealth. The platform enables SMBs to create high-finish ads, without any previous advertising experience, that are optimized for digital...
Affini-T Therapeutics, Inc., a precision immunotherapy company unlocking the power of T cells against oncogenic driver mutations, today announced that data from its preclinical gene edited HLA-A*11:01 KRAS G12D (AFNT-212) and HLA-A*02:01 TP53 R175H T...
H2scan (www.h2scan.com), a leader in solid-state hydrogen sensing solutions, proudly announces a new milestone: more than 1.3 billion hours of field-proven service across a broad range of applications. This achievement includes 700 million hours in...